Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Jordi Rio

Showing results (1-10 of 26) with videos related to

Pageof 3
Sort By:
AJNR. American Journal of Neuroradiology|June 14, 2002
Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case reportAlex Rovira, Imma Pericot, Juli Alonso, et al.
Annals of Neurology|January 26, 2005
Is optic neuritis more benign than other first attacks in multiple sclerosis?Mar Tintoré, Alex Rovira, Jordi Rio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 24, 2017
Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumabPatricia Mulero, Cristina Auger, Laura Parolin, et al.
Plos One|October 23, 2008
Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphismsManuel Comabella, David W Craig, Montse Camiña-Tato, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2022
Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple SclerosisNicolás Fissolo, Agustin Pappolla, Jordi Rio, et al.
Systematic Reviews|July 1, 2022
Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)-a systematic review protocolThomas Lehnert, Christian Röver, Sascha Köpke, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|March 4, 2016
Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume DynamicsAngela Vidal-Jordana, Jaume Sastre-Garriga, Francisco Pérez-Miralles, et al.
European Cytokine Network|December 6, 2003
Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patientsVito Lampasona, Jordi Rio, Diego Franciotta, et al.
Journal of Neuroimmunology|September 13, 2002
The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-betaPablo Villoslada, Lisa F Barcellos, Jordi Rio, et al.
Plos Biology|January 5, 2005
Transcription-based prediction of response to IFNbeta using supervised computational methodsSergio E Baranzini, Parvin Mousavi, Jordi Rio, et al.
Pageof 3

Showing results (1-10 of 26) with videos related to

Sort By:
Pageof 3
AJNR. American Journal of Neuroradiology|June 14, 2002
Serial diffusion-weighted MR imaging and proton MR spectroscopy of acute large demyelinating brain lesions: case reportAlex Rovira, Imma Pericot, Juli Alonso, et al.
Annals of Neurology|January 26, 2005
Is optic neuritis more benign than other first attacks in multiple sclerosis?Mar Tintoré, Alex Rovira, Jordi Rio, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|June 24, 2017
Varicella-zoster meningovasculitis in a multiple sclerosis patient treated with natalizumabPatricia Mulero, Cristina Auger, Laura Parolin, et al.
Plos One|October 23, 2008
Identification of a novel risk locus for multiple sclerosis at 13q31.3 by a pooled genome-wide scan of 500,000 single nucleotide polymorphismsManuel Comabella, David W Craig, Montse Camiña-Tato, et al.
Neurology(R) Neuroimmunology & Neuroinflammation|November 21, 2022
Serum Levels of CXCL13 Are Associated With Teriflunomide Response in Patients With Multiple SclerosisNicolás Fissolo, Agustin Pappolla, Jordi Rio, et al.
Systematic Reviews|July 1, 2022
Immunotherapy for people with clinically isolated syndrome or relapsing-remitting multiple sclerosis: treatment response by demographic, clinical, and biomarker subgroups (PROMISE)-a systematic review protocolThomas Lehnert, Christian Röver, Sascha Köpke, et al.
Journal of Neuroimaging : Official Journal of the American Society of Neuroimaging|March 4, 2016
Brain Volume Loss During the First Year of Interferon-Beta Treatment in Multiple Sclerosis: Baseline Inflammation and Regional Brain Volume DynamicsAngela Vidal-Jordana, Jaume Sastre-Garriga, Francisco Pérez-Miralles, et al.
European Cytokine Network|December 6, 2003
Serial immunoprecipitation assays for interferon--(IFN)-beta antibodies in multiple sclerosis patientsVito Lampasona, Jordi Rio, Diego Franciotta, et al.
Journal of Neuroimmunology|September 13, 2002
The HLA locus and multiple sclerosis in Spain. Role in disease susceptibility, clinical course and response to interferon-betaPablo Villoslada, Lisa F Barcellos, Jordi Rio, et al.
Plos Biology|January 5, 2005
Transcription-based prediction of response to IFNbeta using supervised computational methodsSergio E Baranzini, Parvin Mousavi, Jordi Rio, et al.
Pageof 3